skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 86,410  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients
Material Type:
Article
Add to My Research

The neuroinvasive potential of SARS‐CoV2 may play a role in the respiratory failure of COVID‐19 patients

Journal of Medical Virology, 2020-06, Vol.92 (6) [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;DOI: 10.1002/jmv.25728

Digital Resources/Online E-Resources

2
Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV
Material Type:
Article
Add to My Research

Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV

Nature (London), 2021-06, Vol.594 (7862), p.246-252 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Jun 10, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03493-4 ;PMID: 33845483

Full text available

3
Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series
Material Type:
Article
Add to My Research

Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series

BMJ, 2020-02, Vol.368, p.m606-m606 [Peer Reviewed Journal]

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2020 BMJ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. This work is published under http://creativecommons.org/licenses/by-nc/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 BMJ ;ISSN: 1756-1833 ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m606 ;PMID: 32075786

Digital Resources/Online E-Resources

4
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
Material Type:
Article
Add to My Research

Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV

Viruses, 2020-02, Vol.12 (2), p.244 [Peer Reviewed Journal]

2020 by the authors. 2020 ;ISSN: 1999-4915 ;EISSN: 1999-4915 ;DOI: 10.3390/v12020244 ;PMID: 32098422

Full text available

5
Immunological considerations for COVID-19 vaccine strategies
Material Type:
Article
Add to My Research

Immunological considerations for COVID-19 vaccine strategies

Nature reviews. Immunology, 2020-10, Vol.20 (10), p.615-632 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Springer Nature Limited 2020. ;Springer Nature Limited 2020 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-020-00434-6 ;PMID: 32887954

Full text available

6
Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children
Material Type:
Article
Add to My Research

Coronavirus Infections in Children Including COVID-19: An Overview of the Epidemiology, Clinical Features, Diagnosis, Treatment and Prevention Options in Children

The Pediatric Infectious Disease Journal, 2020-05, Vol.39 (5), p.355 [Peer Reviewed Journal]

2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://healthclarity.wolterskluwer.com/coronavirus-resources.html ;DOI: 10.1097/INF.0000000000002660

Digital Resources/Online E-Resources

7
High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study
Material Type:
Article
Add to My Research

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

Intensive care medicine, 2020-06, Vol.46 (6), p.1089-1098 [Peer Reviewed Journal]

Springer-Verlag GmbH Germany, part of Springer Nature 2020 ;COPYRIGHT 2020 Springer ;Springer-Verlag GmbH Germany, part of Springer Nature 2020. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0342-4642 ;EISSN: 1432-1238 ;DOI: 10.1007/s00134-020-06062-x ;PMID: 32367170

Full text available

8
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2
Material Type:
Article
Add to My Research

The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

Nature Microbiology, 2020-04, Vol.5 (4), p.536-544 [Peer Reviewed Journal]

This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;The Author(s), under exclusive licence to Springer Nature Limited 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s), under exclusive licence to Springer Nature Limited 2020 ;ISSN: 2058-5276 ;EISSN: 2058-5276 ;DOI: 10.1038/s41564-020-0695-z ;PMID: 32123347

Digital Resources/Online E-Resources

9
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody
Material Type:
Article
Add to My Research

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

Science, 2021-02, Vol.371 (6531) [Peer Reviewed Journal]

2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf4830

Digital Resources/Online E-Resources

10
A new coronavirus associated with human respiratory disease in China
Material Type:
Article
Add to My Research

A new coronavirus associated with human respiratory disease in China

Nature, 2020-03, Vol.579 (7798), p.265-269 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Mar 12, 2020 ;2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at http://creativecommons.org/licenses/by/4.0 ;The Author(s) 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2008-3 ;PMID: 32015508

Digital Resources/Online E-Resources

11
A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2
Material Type:
Article
Add to My Research

A Guide to COVID‐19: a global pandemic caused by the novel coronavirus SARS‐CoV‐2

The FEBS journal, 2020-09, Vol.287 (17), p.3633-3650 [Peer Reviewed Journal]

2020 Federation of European Biochemical Societies ;2020 Federation of European Biochemical Societies. ;Copyright © 2020 Federation of European Biochemical Societies ;ISSN: 1742-464X ;EISSN: 1742-4658 ;DOI: 10.1111/febs.15375 ;PMID: 32446285

Full text available

12
Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity
Material Type:
Article
Add to My Research

Attenuation and restoration of severe acute respiratory syndrome coronavirus mutant lacking 2'-o-methyltransferase activity

Journal of virology, 2014-04, Vol.88 (8), p.4251-4264 [Peer Reviewed Journal]

Copyright © 2014, American Society for Microbiology. All Rights Reserved. 2014 American Society for Microbiology ;ISSN: 0022-538X ;EISSN: 1098-5514 ;DOI: 10.1128/jvi.03571-13 ;PMID: 24478444

Full text available

13
The major genetic risk factor for severe COVID-19 is inherited from Neanderthals
Material Type:
Article
Add to My Research

The major genetic risk factor for severe COVID-19 is inherited from Neanderthals

Nature (London), 2020-11, Vol.587 (7835), p.610-612 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Nov 26, 2020 ;ISSN: 0028-0836 ;ISSN: 1476-4687 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2818-3 ;PMID: 32998156

Full text available

14
SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells
Material Type:
Article
Add to My Research

SARS-CoV-2 infection and overactivation of Nlrp3 inflammasome as a trigger of cytokine "storm" and risk factor for damage of hematopoietic stem cells

Leukemia, 2020-07, Vol.34 (7), p.1726-1729 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 0887-6924 ;EISSN: 1476-5551 ;DOI: 10.1038/s41375-020-0887-9 ;PMID: 32483300

Full text available

15
Potently neutralizing and protective human antibodies against SARS-CoV-2
Material Type:
Article
Add to My Research

Potently neutralizing and protective human antibodies against SARS-CoV-2

Nature (London), 2020-08, Vol.584 (7821), p.443-449 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;Copyright Nature Publishing Group Aug 20, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2548-6 ;PMID: 32668443

Full text available

16
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Material Type:
Article
Add to My Research

Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past

Frontiers in immunology, 2020-08, Vol.11, p.1949-1949 [Peer Reviewed Journal]

Copyright © 2020 Shah, Firmal, Alam, Ganguly and Chattopadhyay. ;Copyright © 2020 Shah, Firmal, Alam, Ganguly and Chattopadhyay. 2020 Shah, Firmal, Alam, Ganguly and Chattopadhyay ;ISSN: 1664-3224 ;EISSN: 1664-3224 ;DOI: 10.3389/fimmu.2020.01949 ;PMID: 32849654

Full text available

17
A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment option
Material Type:
Article
Add to My Research

A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus—A possible reference for coronavirus disease‐19 treatment option

Journal of Medical Virology, 2020-06, Vol.92 (6) [Peer Reviewed Journal]

2020. This work is published under http://creativecommons.org/licenses/by/4.0 (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1002/jmv.25729

Digital Resources/Online E-Resources

18
A systematic review of SARS-CoV-2 vaccine candidates
Material Type:
Article
Add to My Research

A systematic review of SARS-CoV-2 vaccine candidates

Signal transduction and targeted therapy, 2020-10, Vol.5 (1), p.237, Article 237 [Peer Reviewed Journal]

The Author(s) 2020 ;ISSN: 2059-3635 ;ISSN: 2095-9907 ;EISSN: 2059-3635 ;DOI: 10.1038/s41392-020-00352-y ;PMID: 33051445

Full text available

19
Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis
Material Type:
Article
Add to My Research

Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the Diamond Princess cruise ship: a retrospective analysis

The Lancet infectious diseases, 2020-09, Vol.20 (9), p.1043-1050 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30482-5 ;PMID: 32539988

Full text available

20
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
Material Type:
Article
Add to My Research

Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion

Proceedings of the National Academy of Sciences - PNAS, 2020-12, Vol.117 (50), p.32105-32113 [Peer Reviewed Journal]

Copyright © 2020 the Author(s). Published by PNAS. ;Copyright National Academy of Sciences Dec 15, 2020 ;Copyright © 2020 the Author(s). Published by PNAS. 2020 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2012197117 ;PMID: 33239446

Full text available

Results 1 - 20 of 86,410  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (67,506)

Refine My Results

Creation Date 

From To
  1. Before 2004  (2,880)
  2. 2004 To 2008  (2,483)
  3. 2009 To 2013  (961)
  4. 2014 To 2019  (868)
  5. After 2019  (79,223)
  6. More options open sub menu

Language 

  1. English  (85,601)
  2. Japanese  (6,093)
  3. Portuguese  (525)
  4. Spanish  (473)
  5. French  (280)
  6. German  (180)
  7. Chinese  (140)
  8. Turkish  (135)
  9. Norwegian  (83)
  10. Polish  (69)
  11. Italian  (64)
  12. Romanian  (42)
  13. Russian  (40)
  14. Korean  (25)
  15. Hungarian  (20)
  16. Slovenian  (19)
  17. Croatian  (17)
  18. Slovak  (8)
  19. Afrikaans  (7)
  20. Bulgarian  (6)
  21. More options open sub menu

Searching Remote Databases, Please Wait